Add Company
Join Now

Belluscura Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • Belluscura has 38 Employees.(i)
  • Belluscura grew their employee count by 0% last year.

Belluscura's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
SVP Engineering, Quality, Regulatory, and ComplianceReveal Email/Phone
4
VP North American SalesReveal Email/Phone
5
Director Sales North AmericaReveal Email/Phone
6
Director Quality & RegulatoryReveal Email/Phone
7
Director Business DevelopmentReveal Email/Phone
8
Engineering DirectorReveal Email/Phone
9
Director Business DevelopmentReveal Email/Phone
10
Finance & Systems ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A45543%N/AN/A
#2
N/A12-29%N/AN/A
#3
$1.7M620%N/AN/A
#4
$15M201-6%N/AN/A
#5
$3.5M15-29%N/AN/A
#6
$15M174-1%$171MN/A
#7
N/A3020%$21.7MN/A
#8
N/A2426%N/AN/A
#9
N/A5736%N/AN/A
#10
N/A83-37%$145MN/A
Add Company

What Is Belluscura?

Belluscura was established in the U.K. as a medical device company focused on developing oxygen enrichment technology to help improve health for Chronic Obstructive Pulmonary Disease (COPD) patients and more favorable economic outcomes for the patient, provider, and insurance companies. COPD is the third leading cause of death in the United States, affecting approximately 30 million people in the U.S. and over 100 million worldwide. Belluscura, now with North American headquarters located in Texas, is dedicated to developing proprietary, patented oxygen enrichment technologies that can be applied across a range of treatment possibilities and positively impact millions of people across the globe.

keywords:N/A

N/A

Total Funding

38

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10M380%N/A
#2
$7.4M3823%N/A
#3
$4.4M38N/AN/A
#4
$8.8M38-41%N/A
#5
$3.5M383%N/A